期刊文献+

恶性黑色素瘤的分子靶向治疗进展 被引量:13

下载PDF
导出
摘要 恶性黑色素瘤(malignant melanoma,MM)是黑色素细胞发生突变形成的恶性肿瘤。其传统治疗方法包括早期手术切除、放疗及化疗。对于晚期患者,靶向治疗可以更准确、有效地缓解病情。目前,对于黑色素瘤的治疗靶点多集中在丝裂原活化蛋白激酶(mitogen-activated protein kinase,MAPK)通路中的B-rapidly accelerated fibrosarcoma(BRAF)、MAPK/细胞外信号调控激酶(mitogen-activated protein kinase/extracellular signal-regulated kinase,MEK)、N-rat sarcoma(NRAS)等变异基因。其分子水平的干预已开始应用于临床,其中BRAF抑制剂和MEK抑制剂已正式批准上市。同时,对于靶向药物单药应用的耐药性以及联合应用的研究也在开展。本文将重点从MAPK通路相关的几种靶向药物及其联合应用对恶性黑色素瘤的分子靶向治疗进行阐述。
出处 《实用肿瘤杂志》 CAS 2017年第6期563-569,共7页 Journal of Practical Oncology
  • 相关文献

参考文献3

二级参考文献40

  • 1Markovic SN, Enickson LA, Rao RO, et al. Maligant melanoma in the 21 st century, partI : Epidermiology, risk factors, screening, prevention, and diagnosis[ J]. Mayo Clinic Proceedings,2007 ;82:364.
  • 2Cummins DL,Cummins JM,Pantle H,et at. Cutaneous maligant melanoma[J]. Mayo Clinproc,2006 ;81:500-7.
  • 3Alavanja MC ,Sandier DP,Lynch CF,et al. Cancer incidence in the agricultural health study[J]. Scand J Work Environ Health,2005 ;31 (Suppl 1 ) :39-45.
  • 4Karagas MR ,Zens MS, Stukel TA, et al. Pregnancy history and incidence of melanoma in women: apooled analysis [ J]. Cancer Causes Control, 2006;17:11-9.
  • 5Tannous ZS, Mihm MC JR, Sober AL, et al. Congental melanocytic nevi: clinical and histopathologic features, risk of melanoma, and clinical management[ J]. J Am Acand dermatol,2005 ;52:197-203.
  • 6Cho E, Rosner BA, Coidite GA. Risk factors for melanoma by body site [ J ]. Cancer Epidemiol Biomarkers Prey ,2005 ; 14 : 1241-4.
  • 7Hollenbeak CS, Todd MM, Billingsley EM, et al. Increasd incidenee of melanoma in renal transplantation recipients [ J ] . Cancer, 2005 ; 104 : 1962-7.
  • 8Zell JA, Cinar P, Mobasher M, et al. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treament[ J]. J Clin 9ncol,2008 ;26( 1 ) :66-7.
  • 9Tuteja R. DNA vaccines;A Ray of hope[J]. Crit Rev Biochem Mol Biol, 1999 ;34 : 1-24.
  • 10Suhrbier A. Mulit-epltope DNA Vaccines[ J]. Immunol Cell Biol, 1997; 75:402-8.

共引文献14

同被引文献84

引证文献13

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部